NIH

Politics Anil Oza

Scientists worry finalizing ‘Schedule F’ rule will further politicize NIH grant decisions

In the Lab Jonathan Wosen

Junior scientists face a quandary when starting their own labs: How far to stray from the hive

Pharmalot Ed Silverman

STAT Plus: As U.S. officials move to reduce animal testing in research, focus may shift to restrictions on imports

Letters to the editor Torie Bosch

STAT readers on shared decision-making, prostate cancer screening, and more

In the Lab Jonathan Wosen

Tenuous biomedical funding has put first-year Ph.D. students in a bind

Politics Megan Molteni

STAT Plus: Unfilled vacancies have depleted NIH advisory councils, key players in grant approvals

Politics Associated Press

Trump administration halts use of human fetal tissue in NIH-funded research

D.C. Diagnosis John Wilkerson

STAT Plus: Congressional health care deal that funds NIH, cracks down on PBMs, expected to pass

In the Lab Angus Chen

STAT Plus: Anthony Letai says NCI is more stable than perceived and is heading for a big year

Politics John Wilkerson and Daniel Payne

STAT Plus: What’s in Congress’ sweeping health care deal: PBM reform, telehealth, science funding

Politics Anil Oza and Jonathan Wosen

STAT Plus: House and Senate appropriators endorse NIH budget increase, reject Trump’s proposed cuts

Politics Anil Oza and John Wilkerson

STAT Plus: Limit on multiyear funding of NIH grants is a sticking point in Senate budget talks

Health Lev Facher

Trump administration reverses course on $1.9 billion in cuts to addiction and mental health grants

First Opinion Sylvia Chou, Paul Grothaus, Alexa Romberg, and Vani Pariyadath

The NIH has lost its scientific integrity. So we left

Politics Jonathan Wosen

STAT Plus: Federal appeals court upholds ruling blocking NIH cap on research overhead payments

Politics Anil Oza

STAT Plus: NIH director says DEI-related grants that were restored under a court order won’t be renewed

Politics Anil Oza

NIH begins review of thousands of delayed research proposals, funding 135 on first day

Politics Jonathan Wosen and Anil Oza

Trump administration agrees to reconsider frozen and denied NIH grant submissions related to DEI

Exclusive Jonathan Wosen

STAT Plus: Director of NIH neurological disorders institute is ousted, adding to leadership churn

First Opinion Sara Rubinelli, Rebecca Ivic, Kenneth H. Rabin, Lawrence O. Gostin, and Scott C. Ratzan

PubMed has competition from Germany. That’s a very good thing

Special Report Eric Boodman

NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled

First Opinion Robert B. Shpiner

5 lessons for U.S. research funding from the AIDS crisis

Health Lev Facher

Trump’s marijuana reclassification could boost research, broaden access

In the Lab Anil Oza and Jonathan Wosen

STAT Plus: NIH funding rates for early-career researchers plunged in 2025, new data show

Special Report Megan Molteni and Anil Oza

As dangerous eugenic ideas spread, NIH falls silent

First Opinion Joshua S. Weitz

What I’ve learned by mapping the impacts of NIH cuts

First Opinion Mikko Packalen

U.S. scientists must compete internationally, just like auto and steel workers do

Special Report Andrew Joseph

Amid talk of a brain drain, some scientists leave U.S. behind

In the Lab Anil Oza

STAT Plus: Former NIH leader Jeanne Marrazzo sues administration over termination